Your browser doesn't support javascript.
loading
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report.
Kim, Haesook T; Ahn, Kwang Woo; Hu, Zhen-Huan; Davids, Matthew S; Volpe, Virginia O; Antin, Joseph H; Sorror, Mohamed L; Shadman, Mazyar; Press, Oliver; Pidala, Joseph; Hogan, William; Negrin, Robert; Devine, Steven; Uberti, Joseph; Agura, Edward; Nash, Richard; Mehta, Jayesh; McGuirk, Joseph; Forman, Stephen; Langston, Amelia; Giralt, Sergio A; Perales, Miguel-Angel; Battiwalla, Minoo; Hale, Gregory A; Gale, Robert Peter; Marks, David I; Hamadani, Mehdi; Ganguly, Sid; Bacher, Ulrike; Lazarus, Hillard; Reshef, Ran; Hildebrandt, Gerhard C; Inamoto, Yoshihiro; Cahn, Jean-Yves; Solh, Melhem; Kharfan-Dabaja, Mohamed A; Ghosh, Nilanjan; Saad, Ayman; Aljurf, Mahmoud; Schouten, Harry C; Hill, Brian T; Pawarode, Attaphol; Kindwall-Keller, Tamila; Saba, Nakhle; Copelan, Edward A; Nathan, Sunita; Beitinjaneh, Amer; Savani, Bipin N; Cerny, Jan; Grunwald, Michael R.
Afiliação
  • Kim HT; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, and Harvard School of Public Health, Boston, Massachusetts. htkimc@jimmy.harvard.edu wsaber@mcw.edu.
  • Ahn KW; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Hu ZH; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Davids MS; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Volpe VO; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Antin JH; Department of Internal Medicine, Division of Oncology's Neag Cancer Center, University of Connecticut Health Center, Farmington, Connecticut.
  • Sorror ML; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Shadman M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Press O; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
  • Pidala J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Hogan W; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
  • Negrin R; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Devine S; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Uberti J; Departments of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, Minnesota.
  • Agura E; Stanford Health Care, Stanford, California.
  • Nash R; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be the Match, Minneapolis, Minnesota.
  • Mehta J; Karmanos Cancer Institute, Detroit, Michigan.
  • McGuirk J; Baylor University Medical Center, Dallas, Texas.
  • Forman S; Colorado Blood Institute, Denver, Colorado.
  • Langston A; Northwestern medicine, Chicago, Illinois.
  • Giralt SA; University of Kansas, Westood, Kansas.
  • Perales MA; City of Hope Medical Center, Duarte, California.
  • Battiwalla M; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Hale GA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gale RP; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Marks DI; Hematology Branch, Sarah Cannon BMT Program, Nashville, Tennessee.
  • Hamadani M; Department of Hematology/Oncology, Johns Hopkins All Children's Hospital, St. Petersburg, Florida.
  • Ganguly S; Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom.
  • Bacher U; Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, United Kingdom.
  • Lazarus H; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Reshef R; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas.
  • Hildebrandt GC; Department of Hematology, Inselspital, Bern University Hospital, Bern, Switzerland.
  • Inamoto Y; Interdisciplinary Clinic for Stem Cell Transplantation, University Cancer Center Hamburg, Hamburg, Germany.
  • Cahn JY; Seidman Cancer Center, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.
  • Solh M; Blood and Marrow Transplantation Program and Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.
  • Kharfan-Dabaja MA; Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
  • Ghosh N; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Saad A; Department of Hematology, CHU Grenoble Alpes, Grenoble, France.
  • Aljurf M; The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, Georgia.
  • Schouten HC; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
  • Hill BT; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina.
  • Pawarode A; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Kindwall-Keller T; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • Saba N; Department of Hematology, Academische Ziekenhuis, Maastricht, the Netherlands.
  • Copelan EA; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Nathan S; Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, Michigan.
  • Beitinjaneh A; Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, Virginia.
  • Savani BN; Tulane University Medical Center, New Orleans, Louisiana.
  • Cerny J; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.
  • Grunwald MR; Rush University Medical Center, Chicago, Illinois.
Clin Cancer Res ; 25(16): 5143-5155, 2019 08 15.
Article em En | MEDLINE | ID: mdl-31253630
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article